Recent Posts

Glaxo’s new CEO pledges to make drugs unit a priority

  Bloomberg Emma Walmsley pledged to spur growth at GlaxoSmithKline Plc’s pharmaceutical unit less than a month after taking over as chief executive officer of the UK’s largest drugmaker. “We are a science-based company,” Walmsley, who had been head of Glaxo’s consumer products division before her appointment in September, told reporters on Wednesday. “Our focus has got to be around ...

Read More »

National defense in face of a media-obsessed White House

  As President Trump nears the 100-day benchmark, it’s a good moment to examine the relationship that has evolved between the mercurial and inexperienced commander in chief and his unflappable Defense Secretary Jim Mattis. It’s an unlikely partnership, but so far it mostly seems to work. Trump may have relatively few domestic-policy accomplishments to show after three months, but he ...

Read More »

Venezuela’s complicated oil crisis

  The cold logic of the oil market dictates that crisis usually equals profit. That’s because a crisis in oil usually means a supply crisis, as some large producing country becomes embroiled in war or civil unrest or sanctions or some other geopolitical mess. The country currently occupying the unenviable position of being the likeliest source of a supply shock ...

Read More »
Send this to a friend